Tennessee Department of Health is recommending medical providers in the state prioritize who receives the monoclonal antibody treatment due to the limited availability of the medicine
Chattanooga, TN – According to the state officials, monoclonal antibody therapies are used to prevent hospitalization and severe disease in COVID-19 positive patients.
The TDH is recommending healthcare providers weigh who really needs the treatment with those who can live without it especially in the first few days of infection.
This includes guidance to prioritize the treatment of those who are most likely to be hospitalized, the unvaccinated, who are 11x more likely to die than vaccinated individuals.
According to the health officials, 44% of Tennesseans are fully vaccinated.
This story will be updated as new information become available.